Maximizing the adequacy of medication treatment in controlled trials and clinical practice: STAR(*)D measurement-based care

Clicks: 505
ID: 118735
2007
The success of well-developed protocols has been limited in real-world practice, where even effective strategies have not been sufficient to meet patient needs in routine clinical care owing to Axis I and III comorbidities. The Sequenced Treatment Alternatives to Relieve Depression (STAR(*)D) trial …
Reference Key
mh2007neuropsychopharmacologymaximizing Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Trivedi MH;Rush AJ;Gaynes BN;Stewart JW;Wisniewski SR;Warden D;Ritz L;Luther JF;Stegman D;Deveaugh-Geiss J;Howland R;;
Journal neuropsychopharmacology : official publication of the american college of neuropsychopharmacology
Year 2007
DOI DOI not found
URL
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=17406651&dopt=Abstract
Keywords
decision making Monitoring National Center for Biotechnology Information NCBI NLM MEDLINE clinical trials as topic humans pubmed abstract nih national institutes of health national library of medicine treatment outcome research support algorithms adult female male N.I.H. Extramural adolescent aged middle aged Clinical Trial follow-up studies physiologic computer-assisted* severity of illness index controlled clinical trial antidepressive agents / therapeutic use* depressive disorder / drug therapy* mental health services / organization & administration* madhukar h trivedi a john rush pmid:17406651 doi:10.1038/sj.npp.1301390 robert howland depressive disorder / physiopathology

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.